Cidara Therapeutics, Inc. (CDTX)
NASDAQ: CDTX · Real-Time Price · USD
220.36
-0.14 (-0.06%)
At close: Dec 5, 2025, 4:00 PM EST
219.64
-0.72 (-0.33%)
After-hours: Dec 5, 2025, 7:16 PM EST
Cidara Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 6,928 | 294 | 72 | 54 | 85 | 88 | |
| Market Cap Growth | 6473.04% | 309.50% | 32.57% | -36.04% | -3.62% | -30.74% | |
| Enterprise Value | 6,510 | 171 | 27 | 3 | 54 | 52 | |
| Last Close Price | 220.36 | 26.88 | 15.88 | 15.13 | 25.40 | 40.00 | |
| PS Ratio | - | 230.62 | 3.08 | 2.31 | 1.71 | 7.28 | |
| PB Ratio | 15.30 | 1.80 | -8.75 | -3.75 | 3.93 | 8.20 | |
| P/TBV Ratio | 16.40 | 1.80 | - | - | 3.93 | 8.20 | |
| EV/Sales Ratio | - | 133.80 | 1.18 | 0.12 | 1.10 | 4.28 | |
| Debt / Equity Ratio | 0.01 | 0.02 | -0.59 | -0.08 | 0.24 | 0.74 | |
| Asset Turnover | - | 0.01 | 0.41 | 0.38 | 0.73 | 0.19 | |
| Quick Ratio | 4.40 | 3.87 | 0.74 | 0.93 | 1.91 | 1.22 | |
| Current Ratio | 4.62 | 4.25 | 0.90 | 1.09 | 2.11 | 1.48 | |
| Return on Equity (ROE) | -68.70% | -219.59% | - | -608.89% | -263.05% | -297.06% | |
| Return on Assets (ROA) | -29.35% | -40.46% | -29.54% | -22.29% | -38.91% | -69.41% | |
| Return on Capital (ROIC) | -36.75% | -69.72% | - | -204.17% | -116.57% | -131.62% | |
| Return on Capital Employed (ROCE) | -37.80% | -55.20% | 6974.20% | -359.80% | -102.30% | -328.70% | |
| Earnings Yield | -2.67% | -57.76% | -31.94% | -62.00% | -50.14% | -82.06% | |
| FCF Yield | -1.92% | -60.08% | -31.94% | -52.79% | -29.84% | -62.13% | |
| Buyback Yield / Dilution | -229.65% | -45.26% | -25.15% | -33.18% | -26.22% | -38.83% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.